Antibiotic use and development of nonalcoholic fatty liver disease: A population‐based case–control study.

MLA

Ebrahimi, Fahim, et al. “Antibiotic Use and Development of Nonalcoholic Fatty Liver Disease: A Population‐based Case–control Study.” Liver International, vol. 43, no. 10, Oct. 2023, pp. 2186–97. EBSCOhost, https://doi.org/10.1111/liv.15663.

APA

Ebrahimi, F., Simon, T. G., Hagström, H., Sun, J., Bergman, D., Forss, A., Roelstraete, B., Engstrand, L., & Ludvigsson, J. F. (2023). Antibiotic use and development of nonalcoholic fatty liver disease: A population‐based case–control study. Liver International, 43(10), 2186–2197. https://doi.org/10.1111/liv.15663

Chicago

Ebrahimi, Fahim, Tracey G. Simon, Hannes Hagström, Jiangwei Sun, David Bergman, Anders Forss, Bjorn Roelstraete, Lars Engstrand, and Jonas F. Ludvigsson. 2023. “Antibiotic Use and Development of Nonalcoholic Fatty Liver Disease: A Population‐based Case–control Study.” Liver International 43 (10): 2186–97. doi:10.1111/liv.15663.